169 related articles for article (PubMed ID: 5554939)
1. The polymorphic acetylation of dapsone in man.
Gelber R; Peters JH; Gordon GR; Glazko AJ; Levy L
Clin Pharmacol Ther; 1971; 12(2):225-38. PubMed ID: 5554939
[No Abstract] [Full Text] [Related]
2. Dapsone acetylation in man: another example of polymorphic acetylation.
Peters JH; Levy L
Ann N Y Acad Sci; 1971 Jul; 179():660-6. PubMed ID: 5285396
[No Abstract] [Full Text] [Related]
3. Polymorphic acetylation of the antibacterials, sulfamethazine and dapsone, in South Indian subjects.
Peters JH; Gordon GR; Karat AB
Am J Trop Med Hyg; 1975 Jul; 24(4):641-8. PubMed ID: 1155699
[TBL] [Abstract][Full Text] [Related]
4. Polymorphic acetylation of drugs in rabbits.
Gordon GR; Shafizadeh AG; Peters JH
Xenobiotica; 1973 Mar; 3(3):133-50. PubMed ID: 4729680
[No Abstract] [Full Text] [Related]
5. The diposition of the antileprotic drug dapsone (DDS) in Philippine subjects.
Peters JH; Gordon GR; Ghoul DC; Tolentino JG; Walsh GP; Levy L
Am J Trop Med Hyg; 1972 Jul; 21(4):450-7. PubMed ID: 4559067
[No Abstract] [Full Text] [Related]
6. Effects of concurrent administration of other substrates of N-acetyltransferase on dapsone acetylation.
Ahmad RA; Rogers HJ; Vandenburg M; Wright P
Br J Clin Pharmacol; 1981 Jul; 12(1):83-6. PubMed ID: 7248142
[No Abstract] [Full Text] [Related]
7. Metabolic disposition of dapsone in patients with dapsone-resistant leprosy.
Peters JH; Gordon GR; Levy L; Strokan MA; Jacobson RR; Enna CD; Kirchheimer WF
Am J Trop Med Hyg; 1974 Mar; 23(2):222-30. PubMed ID: 4817667
[No Abstract] [Full Text] [Related]
8. N-acetylation of drugs: search for INH acetylation polymorphism in baboons.
Radtke HE; Brenner W; Weber WW
Drug Metab Dispos; 1979; 7(3):194-5. PubMed ID: 38093
[No Abstract] [Full Text] [Related]
9. Possible chloroquine-induced modification of N-acetylation of isoniazid and sulphadimidine in the rat.
Nwankwo JO; Garba MA; Chinje CE; Mgbojikwe LO; Emerole GO
Biochem Pharmacol; 1990 Aug; 40(3):654-9. PubMed ID: 2383293
[No Abstract] [Full Text] [Related]
10. [Pharmacokinetics of drug preparations metabolized by N-acetyltransferase].
Skakun NP
Klin Med (Mosk); 1982 Jan; 60(1):24-7. PubMed ID: 6122757
[No Abstract] [Full Text] [Related]
11. Correlation of sulphadimidine acetylation test in urine and blood for isoniazid phenotyping.
Nair CR; Gupta RC; Varshneya AK; Malik SK
Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):646-7. PubMed ID: 6526538
[TBL] [Abstract][Full Text] [Related]
12. Isoniazid and psuedocholinesterase polymorphisms.
La Du BN
Fed Proc; 1972; 31(4):1276-85. PubMed ID: 4556778
[No Abstract] [Full Text] [Related]
13. Acetylator phenotyping: a comparison of the isoniazid and dapsone tests.
Hanson A; Melander A; Wåhlin-Boll E
Eur J Clin Pharmacol; 1981; 20(3):233-4. PubMed ID: 7286042
[TBL] [Abstract][Full Text] [Related]
14. Dapsone acetylation in dermatitis herpetiformis.
Ellard GA; Gammon PT; Savin JA; Tan RS
Br J Dermatol; 1974 Apr; 90(4):441-4. PubMed ID: 4823883
[No Abstract] [Full Text] [Related]
15. Inactivation of isoniazid and sulphadimidine in mongoloid subjects.
Airaksinen E; Mattila MJ; Ollila O
Ann Med Exp Biol Fenn; 1969; 47(4):303-7. PubMed ID: 4246038
[No Abstract] [Full Text] [Related]
16. Blood DDS levels and acetylation rates of sulphadimidine in leprosy patients.
Balakrishnan S; Ramu G
Lepr India; 1977 Jan; 49(1):59-64. PubMed ID: 330945
[TBL] [Abstract][Full Text] [Related]
17. Disease and acetylation polymorphism.
Lunde PK; Frislid K; Hansteen V
Clin Pharmacokinet; 1977; 2(3):182-97. PubMed ID: 328206
[No Abstract] [Full Text] [Related]
18. Effect of cancer chemotherapy on dapsone N-acetylation in man.
Philip PA; Harper PG; Rogers HJ
Cancer Chemother Pharmacol; 1989; 23(6):395-6. PubMed ID: 2713961
[TBL] [Abstract][Full Text] [Related]
19. The effect of rifampicin on dapsone metabolism.
Gelber RH; Gool HC; Rees RJ
Proc West Pharmacol Soc; 1975; 18():330-4. PubMed ID: 1178688
[No Abstract] [Full Text] [Related]
20. An enzyme marker to ensure reliable determinations of human isoniazid acetylator phenotype in vitro.
Hein DW; Hirata M; Weber WW
Pharmacology; 1981; 23(4):203-10. PubMed ID: 6976581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
